{"id":11816,"date":"2026-03-05T18:50:22","date_gmt":"2026-03-05T18:50:22","guid":{"rendered":"https:\/\/medical-article.com\/?p=11816"},"modified":"2026-03-05T18:50:22","modified_gmt":"2026-03-05T18:50:22","slug":"startup-atavistik-adds-40m-for-clinical-trial-in-rare-bleeding-disorder-with-no-approved-therapies","status":"publish","type":"post","link":"https:\/\/medical-article.com\/?p=11816","title":{"rendered":"Startup Atavistik Adds $40M for Clinical Trial in Rare Bleeding Disorder With No Approved Therapies"},"content":{"rendered":"<p><a href=\"https:\/\/medcitynews.com\/2026\/03\/biotech-startup-atavistik-bio-rare-disease-bleeding-hht-allosteric-akt1-inhibitor\/\"><\/a><\/p>\n<p>The Series B extension brings Atavistik Bio\u2019s Series B financing to $160 million. The startup\u2019s lead program is in development for hereditary hemorrhagic telangiectasia (HHT), an inherited bleeding disorder.<\/p>\n<p>The post <a href=\"https:\/\/medcitynews.com\/2026\/03\/biotech-startup-atavistik-bio-rare-disease-bleeding-hht-allosteric-akt1-inhibitor\/\">Startup Atavistik Adds $40M for Clinical Trial in Rare Bleeding Disorder With No Approved Therapies<\/a> appeared first on <a href=\"https:\/\/medcitynews.com\/\">MedCity News<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>The Series B extension brings Atavistik Bio\u2019s Series B financing to $160 million. The startup\u2019s lead program is in development for hereditary hemorrhagic telangiectasia (HHT), an inherited bleeding disorder. The post Startup Atavistik Adds $40M for Clinical Trial in Rare Bleeding Disorder With No Approved Therapies appeared first on MedCity News.<\/p>\n","protected":false},"author":0,"featured_media":11817,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-11816","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicine"],"_links":{"self":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts\/11816"}],"collection":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=11816"}],"version-history":[{"count":0,"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts\/11816\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/media\/11817"}],"wp:attachment":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=11816"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=11816"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=11816"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}